Intrauterine group A streptococcal infections are exacerbated by prostaglandin E2

Journal of Immunology

Volumn 191, Issue 5, 2013, Pages 2457-2465

  Mason, Katie L ^a   Rogers, Lisa M ^a   Soares, Elyara M ^b   Bani Hashemi, Tara ^a   Downward, John Erb ^a   Agnew, Dalen ^c   Peters Golden, Marc ^a   Weinberg, Jason B ^a   Crofford, Leslie J ^d   Aronoff, David M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c MICHIGAN STATE UNIVERSITY   (United States)

^d UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; PROSTAGLANDIN E RECEPTOR 2; PROSTAGLANDIN E RECEPTOR 4; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL POPULATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GROUP A STREPTOCOCCAL INFECTION; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; INTRAUTERINE INFECTION; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CELL LINE; DINOPROSTONE; DISEASE MODELS, ANIMAL; FEMALE; FLOW CYTOMETRY; HUMANS; MICE; MICE, INBRED C57BL; PREGNANCY; PUERPERAL INFECTION; REAL-TIME POLYMERASE CHAIN REACTION; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; UTERUS;

EID: 84883385145     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300786     Document Type: Article

References (67)

1. van Dillen, J., J. Zwart, J. Schutte, and J. van Roosmalen. 2010. Maternal sepsis: epidemiology, etiology and outcome. Curr. Opin. Infect. Dis. 23: 249-254.
2. Sriskandan, S. 2011. Severe peripartum sepsis. J. R. Coll. Physicians Edinb. 41: 339-346.
3. UNICEF. 2008. The state of the world's children 2009: maternal and newborn health. Available at: http://www.unicef.org/media/media-45485.html. Accessed: July 16, 2013.
4. Cone, L. A., D. R. Woodard, P. M. Schlievert, and G. S. Tomory. 1987. Clinical and bacteriologic observations of a toxic shock-like syndrome due to Streptococcus pyogenes. N. Engl. J. Med. 317: 146-149.
5. Mor, G., and I. Cardenas. 2010. The immune system in pregnancy: a unique complexity. Am. J. Reprod. Immunol. 63: 425-433.
6. Deutscher, M., M. Lewis, E. R. Zell, T. H. Taylor, Jr., C. Van Beneden, and S. Schrag; Active Bacterial Core Surveillance Team. 2011. Incidence and severity of invasive Streptococcus pneumoniae, group A Streptococcus, and group B Streptococcus infections among pregnant and postpartum women. Clin. Infect. Dis. 53: 114-123.
7. Goulet, V., M. Hebert, C. Hedberg, E. Laurent, V. Vaillant, H. De Valk, and J. C. Desenclos. 2012. Incidence of listeriosis and related mortality among groups at risk of acquiring listeriosis. Clin. Infect. Dis. 54: 652-660.
8. Davis, S. M., E. A. Clark, L. T. Nelson, and R. M. Silver. 2010. The association of innate immune response gene polymorphisms and puerperal group A streptococcal sepsis. Am. J. Obstet. Gynecol. 202: 308.e1-8.
9. Ricciotti, E., and G. A. FitzGerald. 2011. Prostaglandins and inflammation. Arterioscler. Thromb. Vasc. Biol. 31: 986-1000.
10. Gomez, P. F., M. H. Pillinger, M. Attur, N. Marjanovic, M. Dave, J. Park, C. O. Bingham, III, H. Al-Mussawir, and S. B. Abramson. 2005. Resolution of inflammation: prostaglandin E2 dissociates nuclear trafficking of individual NFkappaB subunits (p65, p50) in stimulated rheumatoid synovial fibroblasts. J. Immunol. 175: 6924-6930.
11. Scher, J. U., and M. H. Pillinger. 2009. The anti-inflammatory effects of prostaglandins. J. Investig. Med. 57: 703-708.
12. St-Onge, M., A. Dumas, A. Michaud, C. Laflamme, A. A. Dussault, and M. Pouliot. 2009. Impact of anti-inflammatory agents on the gene expression profile of stimulated human neutrophils: unraveling endogenous resolution pathways. PLoS ONE 4: e4902.
13. Hoedemaker, M., L. A. Lund, and W. C. Wagner. 1992. Influence of arachidonic acid metabolites and steroids on function of bovine polymorphonuclear neutrophils. Am. J. Vet. Res. 53: 1534-1539.
14. Fabricius, D., M. Neubauer, B. Mandel, C. Schü tz, A. Viardot, A. Vollmer, B. Jahrsdörfer, and K. M. Debatin. 2010. Prostaglandin E2 inhibits IFN-alpha secretion and Th1 costimulation by human plasmacytoid dendritic cells via Eprostanoid 2 and E-prostanoid 4 receptor engagement. J. Immunol. 184: 677-684.
15. Kalínski, P., C. M. Hilkens, A. Snijders, F. G. Snijdewint, and M. L. Kapsenberg. 1997. IL-12-deficient dendritic cells, generated in the presence of prostaglandin E2, promote type 2 cytokine production in maturing human naive T helper cells. J. Immunol. 159: 28-35.
16. Harizi, H., M. Juzan, V. Pitard, J. F. Moreau, and N. Gualde. 2002. Cyclooxygenase-2-issued prostaglandin e(2) enhances the production of endogenous IL-10, which down-regulates dendritic cell functions. J. Immunol. 168: 2255-2263.
17. Kvirkvelia, N., I. Vojnovic, T. D.Warner, V. Athie-Morales, P. Free, N. Rayment, B. M. Chain, T. W. Rademacher, T. Lund, I. M. Roitt, and P. J. Delves. 2002. Placentally derived prostaglandin E2 acts via the EP4 receptor to inhibit IL-2-dependent proliferation of CTLL-2 T cells. Clin. Exp. Immunol. 127: 263-269.
18. Parhar, R. S., and P. K. Lala. 1988. Prostaglandin E2-mediated inactivation of various killer lineage cells by tumor-bearing host macrophages. J. Leukoc. Biol. 44: 474-484.
19. Scodras, J. M., R. S. Parhar, T. G. Kennedy, and P. K. Lala. 1990. Prostaglandinmediated inactivation of natural killer cells in the murine decidua. Cell. Immunol. 127: 352-367.
20. Tawfik, O. W., J. S. Hunt, and G. W. Wood. 1986. Implication of prostaglandin E2 in soluble factor-mediated immune suppression by murine decidual cells. Am. J. Reprod. Immunol. Microbiol. 12: 111-117.
21. Hertelendy, F., R. Woods, and B. M. Jaffe. 1973. Prostaglandin E levels in peripheral blood during labor. Prostaglandins 3: 223-227.
22. Lee, S. E., R. Romero, I. S. Park, H. S. Seong, C. W. Park, and B. H. Yoon. 2008. Amniotic fluid prostaglandin concentrations increase before the onset of spontaneous labor at term. J. Matern. Fetal Neonatal Med. 21: 89-94.
23. Liu, W., S. Dubinett, S. L. Patterson, and K. A. Kelly. 2006. COX-2 inhibition affects growth rate of Chlamydia muridarum within epithelial cells. Microbes Infect. 8: 478-486.
24. Olson, D. M., and C. Ammann. 2007. Role of the prostaglandins in labour and prostaglandin receptor inhibitors in the prevention of preterm labour. Front. Biosci. 12: 1329-1343.
25. Goldmann, O., E. Hertzén, A. Hecht, H. Schmidt, S. Lehne, A. Norrby-Teglund, and E. Medina. 2010. Inducible cyclooxygenase released prostaglandin E2 modulates the severity of infection caused by Streptococcus pyogenes. J. Immunol. 185: 2372-2381.
26. Maloney, C. G., S. D. Thompson, H. R. Hill, J. F. Bohnsack, T. M. McIntyre, and G. A. Zimmerman. 2000. Induction of cyclooxygenase-2 by human monocytes exposed to group B streptococci. J. Leukoc. Biol. 67: 615-621.
27. Medeiros, A. I., C. H. Serezani, S. P. Lee, and M. Peters-Golden. 2009. Efferocytosis impairs pulmonary macrophage and lung antibacterial function via PGE2/EP2 signaling. J. Exp. Med. 206: 61-68.
28. N'Guessan, P. D., S. Hippenstiel, M. O. Etouem, J. Zahlten, W. Beermann, D. Lindner, B. Opitz, M. Witzenrath, S. Rosseau, N. Suttorp, and B. Schmeck. 2006. Streptococcus pneumoniae induced p38 MAPK- and NF-kappaBdependent COX-2 expression in human lung epithelium. Am. J. Physiol. Lung Cell. Mol. Physiol. 290: L1131-L1138.
29. Stables, M. J., J. Newson, S. S. Ayoub, J. Brown, C. J. Hyams, and D. W. Gilroy. 2010. Priming innate immune responses to infection by cyclooxygenase inhibition kills antibiotic-susceptible and -resistant bacteria. Blood 116: 2950-2959.
30. Bennett, P. R., M. P. Rose, L. Myatt, and M. G. Elder. 1987. Preterm labor: stimulation of arachidonic acid metabolism in human amnion cells by bacterial products. Am. J. Obstet. Gynecol. 156: 649-655.
31. Rayon, J. I., J. D. Carver, L. E. Wyble, D. Wiener, S. S. Dickey, V. J. Benford, L. T. Chen, and D. V. Lim. 1997. The fatty acid composition of maternal diet affects lung prostaglandin E2 levels and survival from group B streptococcal sepsis in neonatal rat pups. J. Nutr. 127: 1989-1992.
32. Short, B. L., M. K. Miller, and J. R. Fletcher. 1982. Improved survival in the suckling rat model of group B streptococcal sepsis after treatment with nonsteroidal anti-inflammatory drugs. Pediatrics 70: 343-347.
33. Goldmann, O., M. von Köckritz-Blickwede, C. Höltje, G. S. Chhatwal, R. Geffers, and E. Medina. 2007. Transcriptome analysis of murine macrophages in response to infection with Streptococcus pyogenes reveals an unusual activation program. Infect. Immun. 75: 4148-4157.
34. Aronoff, D. M., Y. Hao, J. Chung, N. Coleman, C. Lewis, C. M. Peres, C. H. Serezani, G. H. Chen, N. Flamand, T. G. Brock, and M. Peters-Golden. 2008. Misoprostol impairs female reproductive tract innate immunity against Clostridium sordellii. J. Immunol. 180: 8222-8230.
35. Soares, E. M., K. L. Mason, L. M. Rogers, C. H. Serezani, L. H. Faccioli, and D. M. Aronoff. 2013. Leukotriene B4 enhances innate immune defense against the puerperal sepsis agent Streptococcus pyogenes. J. Immunol. 190: 1614-1622.
36. Lee, S. P., C. H. Serezani, A. I. Medeiros, M. N. Ballinger, and M. Peters-Golden. 2009. Crosstalk between prostaglandin E2 and leukotriene B4 regulates phagocytosis in alveolar macrophages via combinatorial effects on cyclic AMP. J. Immunol. 182: 530-537.
37. Goldmann, O., M. Rohde, G. S. Chhatwal, and E. Medina. 2004. Role of macrophages in host resistance to group A streptococci. Infect. Immun. 72: 2956-2963.
38. Miettinen, M., A. Lehtonen, I. Julkunen, and S. Matikainen. 2000. Lactobacilli and Streptococci activate NF-kappa B and STAT signaling pathways in human macrophages. J. Immunol. 164: 3733-3740.
39. Veckman, V., M. Miettinen, S. Matikainen, R. Lande, E. Giacomini, E. M. Coccia, and I. Julkunen. 2003. Lactobacilli and streptococci induce inflammatory chemokine production in human macrophages that stimulates Th1 cell chemotaxis. J. Leukoc. Biol. 74: 395-402.
40. Qiu, X., L. Zhu, and J. W. Pollard. 2009. Colony-stimulating factor-1-dependent macrophage functions regulate the maternal decidua immune responses against Listeria monocytogenes infections during early gestation in mice. Infect. Immun. 77: 85-97.
41. Aronoff, D. M., I. L. Bergin, C. Lewis, D. Goel, E. O'Brien, M. Peters-Golden, and P. Mancuso. 2012. E-prostanoid 2 receptor signaling suppresses lung innate immunity against Streptococcus pneumoniae. Prostaglandins Other Lipid Mediat. 98: 23-30.
42. Trebino, C. E., J. L. Stock, C. P. Gibbons, B. M. Naiman, T. S. Wachtmann, J. P. Umland, K. Pandher, J. M. Lapointe, S. Saha, M. L. Roach, et al. 2003. Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase. Proc. Natl. Acad. Sci. USA 100: 9044-9049.
43. Chatellier, S., N. Ihendyane, R. G. Kansal, F. Khambaty, H. Basma, A. Norrby-Teglund, D. E. Low, A. McGeer, and M. Kotb. 2000. Genetic relatedness and superantigen expression in group A streptococcus serotype M1 isolates from patients with severe and nonsevere invasive diseases. Infect. Immun. 68: 3523-3534.
44. Aziz, R. K., R. Kansal, N. F. Abdeltawab, S. L. Rowe, Y. Su, D. Carrigan, M. M. Nooh, R. R. Attia, C. Brannen, L. A. Gardner, et al. 2007. Susceptibility to severe Streptococcal sepsis: use of a large set of isogenic mouse lines to study genetic and environmental factors. Genes Immun. 8: 404-415.
45. Aziz, R. K., M. J. Pabst, A. Jeng, R. Kansal, D. E. Low, V. Nizet, and M. Kotb. 2004. Invasive M1T1 group A Streptococcus undergoes a phase-shift in vivo to prevent proteolytic degradation of multiple virulence factors by SpeB. Mol. Microbiol. 51: 123-134.
46. Abdeltawab, N. F., R. K. Aziz, R. Kansal, S. L. Rowe, Y. Su, L. Gardner, C. Brannen, M. M. Nooh, R. R. Attia, H. A. Abdelsamed, et al. 2008. An unbiased systems genetics approach to mapping genetic loci modulating susceptibility to severe streptococcal sepsis. PLoS Pathog. 4: e1000042.
47. Arredouani, M., Z. Yang, Y. Ning, G. Qin, R. Soininen, K. Tryggvason, and L. Kobzik. 2004. The scavenger receptor MARCO is required for lung defense against pneumococcal pneumonia and inhaled particles. J. Exp. Med. 200: 267-272.
48. Hashidate, T., N. Murakami, M. Nakagawa, M. Ichikawa, M. Kurokawa, T. Shimizu, and M. Nakamura. 2010. AML1 enhances the expression of leukotriene B4 type-1 receptor in leukocytes. FASEB J. 24: 3500-3510.
49. Daigneault, M., J. A. Preston, H. M. Marriott, M. K. Whyte, and D. H. Dockrell. 2010. The identification of markers of macrophage differentiation in PMAstimulated THP-1 cells and monocyte-derived macrophages. PLoS ONE 5: e8668.
50. Vince, G. S., P. M. Starkey, M. C. Jackson, I. L. Sargent, and C. W. Redman. 1990. Flow cytometric characterisation of cell populations in human pregnancy decidua and isolation of decidual macrophages. J. Immunol. Methods 132: 181-189.
51. Thelen, T., Y. Hao, A. I. Medeiros, J. L. Curtis, C. H. Serezani, L. Kobzik, L. H. Harris, and D. M. Aronoff. 2010. The class A scavenger receptor, macrophage receptor with collagenous structure, is the major phagocytic receptor for Clostridium sordellii expressed by human decidual macrophages. J. Immunol. 185: 4328-4335.
52. Peres, C. M., D. M. Aronoff, C. H. Serezani, N. Flamand, L. H. Faccioli, and M. Peters-Golden. 2007. Specific leukotriene receptors couple to distinct G proteins to effect stimulation of alveolar macrophage host defense functions. J. Immunol. 179: 5454-5461.
53. Aronoff, D. M., C. Canetti, and M. Peters-Golden. 2004. Prostaglandin E2 inhibits alveolar macrophage phagocytosis through an E-prostanoid 2 receptormediated increase in intracellular cyclic AMP. J. Immunol. 173: 559-565.
54. Aronoff, D. M., C. Lewis, C. H. Serezani, K. A. Eaton, D. Goel, J. C. Phipps, M. Peters-Golden, and P. Mancuso. 2009. E-prostanoid 3 receptor deletion improves pulmonary host defense and protects mice from death in severe Streptococcus pneumoniae infection. J. Immunol. 183: 2642-2649.
55. Shynlova, O., T. Nedd-Roderique, Y. Li, A. Dorogin, and S. J. Lye. 2013. Myometrial immune cells contribute to term parturition, preterm labour and post-partum involution in mice. J. Cell. Mol. Med. 17: 90-102.
56. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
57. Carapetis, J. R., A. C. Steer, E. K. Mulholland, and M. Weber. 2005. The global burden of group A streptococcal diseases. Lancet Infect. Dis. 5: 685-694.
58. Aronoff, D. M., and Z. D. Mulla. 2008. Postpartum invasive group A streptococcal disease in the modern era. Infect. Dis. Obstet. Gynecol. 2008: 796892.
59. Mason, K. L., and D. M. Aronoff. 2012. Postpartum group a Streptococcus sepsis and maternal immunology. Am. J. Reprod. Immunol. 67: 91-100.
60. Ballinger, M. N., D. M. Aronoff, T. R. McMillan, K. R. Cooke, K. Olkiewicz, G. B. Toews, M. Peters-Golden, and B. B. Moore. 2006. Critical role of prostaglandin E2 overproduction in impaired pulmonary host response following bone marrow transplantation. J. Immunol. 177: 5499-5508.
61. Sadikot, R. T., H. Zeng, A. C. Azim, M. Joo, S. K. Dey, R. M. Breyer, R. S. Peebles, T. S. Blackwell, and J. W. Christman. 2007. Bacterial clearance of Pseudomonas aeruginosa is enhanced by the inhibition of COX-2. Eur. J. Immunol. 37: 1001-1009.
62. Thulin, P., L. Johansson, D. E. Low, B. S. Gan, M. Kotb, A. McGeer, and A. Norrby-Teglund. 2006. Viable group A streptococci in macrophages during acute soft tissue infection. PLoS Med. 3: e53.
63. Johansson, L., P. Thulin, P. Sendi, E. Hertzén, A. Linder, P. Akesson, D. E. Low, B. Agerberth, and A. Norrby-Teglund. 2008. Cathelicidin LL-37 in severe Streptococcus pyogenes soft tissue infections in humans. Infect. Immun. 76: 3399-3404.
64. Bryant, A. E., C. R. Bayer, J. D. Huntington, and D. L. Stevens. 2006. Group A streptococcal myonecrosis: increased vimentin expression after skeletal-muscle injury mediates the binding of Streptococcus pyogenes. J. Infect. Dis. 193: 1685-1692.
65. Hamilton, S. M., C. R. Bayer, D. L. Stevens, R. L. Lieber, and A. E. Bryant. 2008. Muscle injury, vimentin expression, and nonsteroidal anti-inflammatory drugs predispose to cryptic group A streptococcal necrotizing infection. J. Infect. Dis. 198: 1692-1698.
66. Mishalian, I., M. Ordan, A. Peled,A. Maly,M.B. Eichenbaum, M. Ravins, T.Aychek, S. Jung, and E. Hanski. 2011. Recruited macrophages control dissemination of group A Streptococcus from infected soft tissues. J. Immunol. 187: 6022-6031.
67. von Moltke, J., N. J. Trinidad, M. Moayeri, A. F. Kintzer, S. B. Wang, N. van Rooijen, C. R. Brown, B. A. Krantz, S. H. Leppla, K. Gronert, and R. E. Vance. 2012. Rapid induction of inflammatory lipid mediators by the inflammasome in vivo. Nature 490: 107-111.